Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

5:20 PM - 5:25 PM PT

5-Year Results of a Prospective, Non-Randomized Controlled Study: Comparison of the Efficacy and Safety of ADT + Docetaxel vs. ADT + Novel Hormone Therapy in High Gleason Score Non-Metastatic Prostate
Speaker: Ma, Mingwei, MD - Peking University First Hospital, Beijing, Beijing
5:25 PM - 5:30 PM PT

1079 - Effect of Radiation Dose on Lymphedema Development Following Immediate Lymphatic Reconstruction and Axillary Lymph Node Dissection
Speaker: Spiegel, Daphna, MD, MS - Beth Israel Deaconess Medical Center, Boston, Massachusetts
5:25 PM - 5:30 PM PT

1085 - A Phase I/Ib, Single Arm Study of Two Fraction SBRT with SIB for the Treatment of Localized Prostate Cancer: Early Toxicity Outcomes
Speaker: Lischalk, Jonathan, MD - NYU Langone Health - Long Island, Mineola, NY
5:25 PM - 5:30 PM PT

1091 - HYPCON 03 Pilot Study: A Study Exploring Delivery of 3Gy per Fraction in Post Operative Radiotherapy for Head and Neck Carcinomas
Speaker: Sharma, Aman, MD, DO, DSc - All India Institute of Medical Sciences, Healthcare, Practitioner and Technician, Delhi
5:25 PM - 5:30 PM PT

1097 - Response Rate and Local Control of Response-Adapted Very Low Dose Radiotherapy (RA-VLDRT) with 4 Gy for Indolent Non-Hodgkin Lymphoma
Speaker: Mankuzhy, Nikhil, MD - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ
5:25 PM - 5:30 PM PT

1103 - SETD2 Loss Predicts Response to Chemoradiotherapy in Rectal Cancer: Clinical Outcomes and Preclinical Validation in Orthotopic Models
Speaker: Megahed, Romy, MD - UAMS Radiation Oncology, Little Rock, AR
5:30 PM - 5:35 PM PT

1080 - Residual Nodal Disease after Positive Sentinel Lymph Node Biopsy in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Implication for Completion Dissection
Speaker: Dvorak, Tomas, MD - Orlando Health Cancer Institute, Orlando, FL
5:30 PM - 5:35 PM PT

1086 - Identifying Optimal Candidates for PSMA PET Staging of Newly Diagnosed Intermediate Risk Prostate Cancer: A Report from the National Veterans Affairs System
Speaker: Tang, Joseph, MD, BS - University of Michigan, Ann Arbor, MI
5:30 PM - 5:35 PM PT

1092 - Clinical Outcome and Toxicities of Post-Operative Hypofractionated Intensity Modulated Radiation Therapy for Oral Cavity Squamous Cell Carcinoma: A Phase II Study
Speaker: Gandhi, Ajeet, MD, DNB - Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh
5:30 PM - 5:35 PM PT

1098 - Optimizing Palliative Radiation Therapy for Primary Cutaneous B-Cell Lymphoma: Is Ultra-Low Dose (4 Gy) Enough?
Speaker: Gard, Gabrielle, BS - University of Texas Southwestern Medical Center, Dallas, TX
5:30 PM - 5:35 PM PT

1104 - Radiation-Induced HACE1 Suppression Drives Metastatic Progression in Lung Cancer through Actin Cytoskeletal Remodeling
Speaker: Huang, Hao, PhD - Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xian, Shanxi
5:35 PM - 5:40 PM PT

1081 - Incidence and Impact of Incidental Findings in Breast Radiotherapy CT Simulation
Speaker: Matous, Allison, MD - Dartmouth-Hitchcock Medical Center, Lebanon, NH